Free Trial
CVE:PTF

Pender Growth Fund (PTF) Stock Price, News & Analysis

Pender Growth Fund logo
C$14.89 +0.40 (+2.76%)
As of 08/1/2025 10:08 AM Eastern

About Pender Growth Fund Stock (CVE:PTF)

Key Stats

Today's Range
C$14.40
C$14.89
50-Day Range
C$10.15
C$14.89
52-Week Range
C$9.29
C$14.99
Volume
2,800 shs
Average Volume
3,006 shs
Market Capitalization
C$107.96 million
P/E Ratio
2.40
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pender Growth Fund and its competitors with MarketBeat's FREE daily newsletter.

PTF Stock News Headlines

China just unlocked Nvidia’s AI chips—what that means for you
Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.
See More Headlines

PTF Stock Analysis - Frequently Asked Questions

Pender Growth Fund's stock was trading at C$11.19 at the beginning of 2025. Since then, PTF shares have increased by 33.1% and is now trading at C$14.89.

Shares of PTF stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Pender Growth Fund investors own include Armata Pharmaceuticals (ARMP), BioCardia (BCDA), Bristol Myers Squibb (BMY), Range Cancer Therapeutics ETF (CNCR), Inovio Pharmaceuticals (INO), Insight Select Income Fund (INSI) and Protalix BioTherapeutics (PLX).

Industry, Sector and Symbol

Stock Exchange
CVE
Industry
Asset Management
Sub-Industry
N/A
Current Symbol
CVE:PTF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C$6.20
Trailing P/E Ratio
2.40
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
C$44.92 million
Net Margins
90.98%
Pretax Margin
N/A
Return on Equity
49.26%
Return on Assets
25.87%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
51.12

Sales & Book Value

Annual Sales
C$49.38 million
Price / Sales
2.19
Cash Flow
C$1.78 per share
Price / Cash Flow
8.35
Book Value
C$15.08 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
7,250,430
Free Float
N/A
Market Cap
C$107.96 million
Optionable
Not Optionable
Beta
0.56
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (CVE:PTF) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners